Literature DB >> 8383643

Alteration of active Na-K transport on protein kinase C activation in cultured ciliary epithelium.

T Mito1, N A Delamere.   

Abstract

PURPOSE: Experiments were conducted to test whether protein kinase C activation causes changes in active sodium-potassium transport in an established SV-40 transformed line (ODM2) of cultured human nonpigmented ciliary epithelial cells.
METHODS: Rubidium-86 (86Rb) uptake was measured and the data used to determine the rate of potassium entry into the cells.
RESULTS: Protein kinase C activator, phorbol dibutyrate (PDBu), caused a stimulation of ouabain-sensitive 86Rb uptake. Inhibition of protein kinase C by 1-(5-isoquinolinylsulfonyl) 2-methylpiperazine (H-7), or down-regulation of protein kinase C activation by prolonged exposure of PDBu, decreased the PDBu response. These results suggest that protein kinase C plays a role in Na-K pump activation. The Na/H+ exchanger inhibitor, amiloride, also reduced the stimulation of the ouabain-sensitive 86Rb uptake by PDBu. 86Rb efflux was not altered by protein kinase C activation. At the same time that PDBu increased the ouabain-sensitive 86Rb uptake, it also decreased the ouabain-insensitive 86Rb uptake. The ouabain-insensitive 86Rb uptake component could be inhibited by bumetanide, suggesting that protein kinase C activation decreases the activity of a Na/K/2Cl cotransporter.
CONCLUSIONS: These findings suggest that activation of protein kinase C may stimulate Na,K-ATPase activity mainly by a mechanism involving increased Na+ influx mediated by the Na+/H+ exchanger.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383643

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  1 in total

1.  [Ca2+]i determines the effects of protein kinases A and C on activity of rat renal Na+,K+-ATPase.

Authors:  S X Cheng; O Aizman; A C Nairn; P Greengard; A Aperia
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.